Loading clinical trials...
Loading clinical trials...
An Investigator-Initiated, Single Center, Prospective, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety and Efficacy of OnabotulinumtoxinA (BOTOX®) in Adults With Moderate Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Interventions
OnabotulinumtoxinA
Placebo
Locations
1
United States
Tranquil Clinical Research
Webster, Texas, United States
Start Date
October 1, 2023
Primary Completion Date
April 24, 2024
Completion Date
July 10, 2024
Last Updated
July 17, 2024
NCT07307781
NCT07383896
NCT07518472
NCT07509606
NCT07451977
NCT07477600
Lead Sponsor
RMW Testing
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions